Back

Isolation of and Characterization of Neutralizing Antibodies to Covid-19 from a Large Human Naïve scFv Phage Display Library

Yuan, A. Q.

2020-05-19 immunology
10.1101/2020.05.19.104281 bioRxiv
Show abstract

SARS-CoV-2 (Covid-19) has caused currently ongoing global plague and imposed great challenges to health managing systems all over the world, with millions of infections and hundreds of thousands of deaths. In addition to racing to develop vaccines, neutralizing antibodies (nAbs) to this virus have been extensively sought and are expected to provide another prevention and therapy tool against this frantic pandemic. To offer fast isolation and shortened early development, a large human naive phage display antibody library, was built and used to screen specific nAbs to the receptor-binding domain, RBD, the key for Covid-19 virus entry through a human receptor, ACE2. The obtained RBD-specific antibodies were characterized by epitope mapping, FACS and neutralization assay. Some of the antibodies demonstrated spike-neutralizing property and ACE2-competitiveness. Our work proved that RBD-specific neutralizing binders from human naive antibody phage display library are promising candidates to for further Covid-19 therapeutics development.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Antibody Therapeutics
16 papers in training set
Top 0.1%
12.9%
2
Vaccines
198 papers in training set
Top 0.2%
12.1%
3
Scientific Reports
3612 papers in training set
Top 4%
9.9%
4
Frontiers in Immunology
638 papers in training set
Top 2%
6.9%
5
PLOS ONE
5266 papers in training set
Top 28%
5.6%
6
iScience
1154 papers in training set
Top 7%
3.2%
50% of probability mass above
7
mAbs
32 papers in training set
Top 0.2%
2.8%
8
Heliyon
152 papers in training set
Top 2%
2.7%
9
Journal of Medical Virology
140 papers in training set
Top 1%
2.4%
10
Cells
249 papers in training set
Top 2%
2.4%
11
Antiviral Research
50 papers in training set
Top 0.3%
2.2%
12
Nature Communications
5641 papers in training set
Top 44%
1.8%
13
Viruses
332 papers in training set
Top 3%
1.8%
14
ACS Infectious Diseases
82 papers in training set
Top 1.0%
1.4%
15
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.4%
16
Protein Science
246 papers in training set
Top 3%
1.1%
17
Frontiers in Molecular Biosciences
102 papers in training set
Top 2%
1.0%
18
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.5%
1.0%
19
Journal of Virology
499 papers in training set
Top 3%
1.0%
20
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.5%
0.9%
21
Cell Reports
1498 papers in training set
Top 26%
0.9%
22
Molecular Therapy
81 papers in training set
Top 2%
0.9%
23
eLife
5828 papers in training set
Top 68%
0.6%
24
Virologica Sinica
11 papers in training set
Top 0.2%
0.6%
25
International Journal of Biological Macromolecules
76 papers in training set
Top 2%
0.6%